We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Image: The modified culture medium speeds fidaxomicin resistance detection while reducing material and labor demands (image credit: Adobe Stock)

New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs

A modified culture medium speeds detection of fidaxomicin-resistant C. difficile with 100% sensitivity. More...
09 Jun 2026
Image: The fully automated solution increases vial loading by 50% and supports up to 960 vials per module, extending walk-away time (Photo courtesy of Waters Corporation)

Automated Blood Culture System Speeds Detection of Bloodstream Infections

The BD BACTEC FXI Culture System has received FDA 510(k) clearance and is now available to U.S. laboratories. More...
09 Jun 2026
Image: Roche developed a research-use PCR assay within six days of the Bundibugyo virus genome sequence being published (image credit: Adobe Stock)

New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

A new research-use PCR test detects Bundibugyo virus to support faster outbreak response. More...
08 Jun 2026
Image: Under the agreement, Natera will evaluate ctDNA from clinical trial samples collected in CytoDyn’s CLOVER Phase 2 study

Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

A personalized ctDNA-based MRD test assesses residual disease and response in metastatic CRC to inform leronlimab development. More...
08 Jun 2026
Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: Graphical abstract (Pandya T, Zagorulya M, Leung MM, et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 2026. doi:10.1016/j.cell.2026.05.005)

Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

A 14-protein blood signature predicts lung cancer risk up to five years before diagnosis, beyond smoking status. More...
05 Jun 2026
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Immunofluorescence Analyzer
IFA System
Copyright © 2000-2026 Globetech Media. All rights reserved.